Bennett Audrey, Bery Alexandra, Esposito Patricia, Zickgraf Hana, Adams Dawn W
Department of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee.
Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Gastro Hep Adv. 2022 Mar 30;1(3):321-327. doi: 10.1016/j.gastha.2022.01.002. eCollection 2022.
The objective of this study was to identify the prevalence of avoidant/restrictive food intake disorder (ARFID) in patients with celiac disease (CD) and assess metabolic complications, disease control, diet adherence, and correlation with symptom and quality-of-life metrics.
This was a retrospective study of 137 adult patients with CD who completed an ARFID survey in the CD clinic between 2018 and 2020. Demographics, clinical results, standardized diet assessment, and results of Celiac Disease Symptom Diary and Impact of a Gluten-free Diet Questionnaire were reviewed. The primary outcome measured was the rate of suspected ARFID based on patient-reported survey responses.
Seventy-eight patients (57%) met suspected ARFID criteria. There were no differences in age, gender, body mass index, micronutrient deficiencies, or bone disease in those with or without ARFID. Patients with ARFID did not have a difference in biopsy activity or better adherence to a gluten-free diet compared with non-ARFID patients. Food and social burden on Impact of a Gluten-free Diet Questionnaire was most predictive of ARFID.
ARFID is common and has a high impact in patients with CD. Although some eating behavior is certainly due to their CD, there was no distinct difference in disease control between those with or without suspected ARFID, suggesting these maladaptive behaviors are not necessary for disease control. We did not find increased metabolic complications, but this was a 2-year snapshot. We need to further understand the social and food impacts on patients who score high on this survey to prevent further deficiencies and impaired, long-term detrimental eating behaviors.
本研究的目的是确定乳糜泻(CD)患者中回避/限制型食物摄入障碍(ARFID)的患病率,并评估代谢并发症、疾病控制情况、饮食依从性以及与症状和生活质量指标的相关性。
这是一项对137例成年CD患者的回顾性研究,这些患者于2018年至2020年间在CD诊所完成了ARFID调查。回顾了人口统计学资料、临床结果、标准化饮食评估以及乳糜泻症状日记和无麸质饮食问卷影响的结果。主要测量结果是基于患者报告的调查回复得出的疑似ARFID发生率。
78例患者(57%)符合疑似ARFID标准。有或没有ARFID的患者在年龄、性别、体重指数、微量营养素缺乏或骨病方面没有差异。与非ARFID患者相比,ARFID患者在活检活性或对无麸质饮食的更好依从性方面没有差异。无麸质饮食问卷影响中的食物和社会负担最能预测ARFID。
ARFID在CD患者中很常见且影响很大。虽然某些饮食行为肯定归因于他们的CD,但有或没有疑似ARFID的患者在疾病控制方面没有明显差异,这表明这些适应不良行为对于疾病控制并非必要。我们没有发现代谢并发症增加,但这只是一个两年的快照。我们需要进一步了解对该调查得分高的患者的社会和食物影响,以预防进一步的营养缺乏和有害的长期饮食行为。